Prevalence of Anti SARS CoV 2 Antibody in COVID 19 Patients in Japan

The continued spread of coronavirus disease 2019 COVID 19 has prompted widespread concern around the world, and the World Health Organization WHO , on 11 March 2020, declared COVID 19 a pandemic. The significance of performing an antibody test against SARS CoV 2 using serum is to identify asymptomatic SARS CoV 2 infected individuals. Our research group has been studying the prevalence of anti severe acute respiratory syndrome coronavirus 2 SARS CoV 2 antibodies in SARS CoV 2 infected Japanese individuals. Within 20 days after symptom onset, 100 of patients tested positive for antiviral immunoglobulin G IgG . Seroconversion for IgG and IgM occurred simultaneously or sequentially. Both IgG and IgM titers plateaued within 6 days after seroconversion. 

by Takuma Hayashi | Ikuo Konishi "Prevalence of Anti-SARS-CoV-2 Antibody in COVID-19 Patients in Japan" 

Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-3 , April 2021, 

URL: https://www.ijtsrd.com/papers/ijtsrd39857.pdf 

Paper URL: https://www.ijtsrd.com/medicine/other/39857/prevalence-of-antisarscov2-antibody-in-covid19-patients-in-japan/takuma-hayashi

callforpaperpapersinjournals, multidisciplinaryjournal